# Natalie Staplin

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/natalie-staplin/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,072 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 45 |
| i10-index | 80 |
| Last Known Institution | University of Oxford |
| OpenAlex ID | https://openalex.org/A5028314395 |
| ORCID iD | https://orcid.org/0000-0003-4482-4418 |
| Works | 163 |

## Researcher papers

- [Dexamethasone in Hospitalized Patients with Covid-19.](https://scholariq.org/papers/dexamethasone-in-hospitalized-patients-with-covid-19/)
- [Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials](https://scholariq.org/papers/impact-of-diabetes-on-the-effects-of-sodium-glucose-co-transporter-2-inhibitors/)
- [Effect of Dexamethasone in Hospitalized Patients with COVID-19 – Preliminary Report](https://scholariq.org/papers/effect-of-dexamethasone-in-hospitalized-patients-with-covid-19-preliminary/)
- [Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial](https://scholariq.org/papers/lopinavir-ritonavir-in-patients-admitted-to-hospital-with-covid-19-recovery-a/)
- [The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study](https://scholariq.org/papers/the-potential-for-improving-cardio-renal-outcomes-by-sodium-glucose-co/)
- [Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-sglt2-inhibitors-with-and-without-glucagon-like-peptide-1/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

## Researcher university

- [University of Oxford](https://scholariq.org/institutions/university-of-oxford/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.